Press releases

Boston Scientific will webcast its conference call discussing financial results and business highlights for Q4 ended December 31, 2018. Learn how to tune in.

Acquisition will expand structural heart portfolio to include transcatheter mitral annuloplasty repair system

A live webcast and replay will be available. Learn how to tune in.

Delaware court rules Edwards Lifesciences Infringes Boston Scientific patent

Boston Scientific will participate in a healthcare investor conference in December 2018. A live webcast and replay will be available.

Boston Scientific will participate in Citi’s healthcare investor conference in December 2018. A live webcast and replay will be available.

In helping care for people living with complex, debilitating and often life-threatening conditions, patient safety is Boston Scientific’s highest priority.

Boston Scientific will participate the healthcare investor conference in November 2018. A live webcast and replay will be available.

Transaction would expand Boston Scientific peripheral interventions portfolio with minimally invasive treatments for cancers and vascular conditions

Boston Scientific will participate in a medtech conference in November 2018. A live webcast and replay will be available.

Boston Scientific Corporation (NYSE: BSX) will participate in the Stifel 2018 Healthcare Conference on Tuesday, November 13, 2018 in New York City. Dan Brennan, executive vice president and chief...

Boston Scientific Corporation (NYSE: BSX) will participate in the 27th Annual Credit Suisse Healthcare Conference on Wednesday, November 14, 2018 in Scottsdale, Arizona. Joe Fitzgerald, executive...

"Through internal research and tuck-in acquisitions, we continue to bring meaningful innovations to market,” said CEO Mike Mahoney.

Court rules Edwards Lifesciences’ next-generation valve infringes Boston Scientific patent and grants right to enjoin sales in Germany.

The acquisition brings SpaceOAR, which decreases exposure to rectal radiation during prostate cancer radiotherapy, into the Boston Scientific portfolio.

Data support minimally invasive single-incision mesh procedure as a durable, safe and effective treatment for stress urinary incontinence.

4th annual Connected Patient Challenge focuses on using population health data, patient monitoring or predictive analytics to improve care and lower costs.

Boston Scientific will webcast its conference call with financial results and business highlights for Q3 ended September 30, 2018. Learn how to tune in.

Eluvia is the first peripheral vascular interventional technology approved in U.S. to offer a sustained release of a drug to treat peripheral artery disease.

First head-to-head trial assesses effectiveness of sustained drug release in interventional treatment for patients with blockages in femoropopliteal arteries.

New data at World Congress of Endourology demonstrate the Lithovue Empower device for kidney stone retrieval improves the OR experience.

Key data will include results from IMPERIAL trial evaluating ELUVIA drug-eluting stent and from REPRISE III study evaluating LOTUS Aortic Valve System.

Acquisition expands Boston Scientific portfolio of men's health in-office procedures with SpaceOAR, an adjunctive therapy for prostate cancer patients.

Boston Scientific will participate in the upcoming healthcare conference in September 2018. A live webcast and replay will be available.

Boston Scientific will participate in the upcoming healthcare conference on Sept. 5, 2018. A live webcast and replay will be available.